No Data
Xiamen Yan Palace Bird's Nest Industry's Attributable Profit Slides in 2024
YAN PALACE subscribes to structured deposit products.
YAN PALACE (01497) announced that on January 3, 2025, the company's wholly-owned subsidiary YAN PALACE Silk Nourishing Biotechnology entered into a structured deposit product agreement I with CEB BANK. According to this, YAN PALACE Silk Nourishing Biotechnology agreed to subscribe to structured deposit product I of 45 million RMB with CEB BANK. The subscribed structured deposit product I was fully redeemed on March 3, 2025. On January 6, 2025, the company's wholly-owned subsidiary YAN PALACE Silk Nourishing Biotechnology entered into a structured deposit product agreement II with CEB BANK, according to which YAN PALACE Silk Nourishing Biotechnology agreed to subscribe to Chinese light.
Xiamen Yan Palace Declares Final Dividend for 2024
Xiamen Yan Palace Updates Nomination Committee for Enhanced Governance
YAN PALACE (01497): Xiao Wei has been appointed as the chairman of the nomination committee.
YAN PALACE (01497) announced that effective from March 14, 2025: (i) the company's Executive Director and the Director...
YAN PALACE (01497.HK) reported a year-on-year revenue increase of 4.37% to 2.05 billion yuan in 2024.
On March 14th, GELONGHUI reported that YAN PALACE (01497.HK) announced its performance for the year ending December 31, 2024, with revenue increasing by 4.37% year-on-year to 2.05 billion yuan; profit was 0.16 billion yuan; basic and diluted earnings per share were 0.34 yuan. Looking back over the past year, the external environment has been complex and changeable, consumer demand has increasingly diversified, and competition in the industry has reached a fever pitch, making this undoubtedly a very challenging year in the group's development history. In the face of such complex circumstances, the company has made every effort to promote its brand's high-end strategy, actively explore new channel layouts, and innovate and enrich its product matrix, achieving
